Search Results - "Pérez Altozano, Javier"

Seroprevalence and immunological memory against SARS-CoV-2 in lung cancer patients: the SOLID study by Provencio, Mariano, Rodríguez-Abreu, Delvys, Ortega, Ana L., Serrano, Gloria, Aguado, Carlos, Franco, Fernando, Gutierrez, Vanesa, López Vivanco, Guillermo, Guirado, María, Benítez, Gretel, Estival, Anna, Calvo, Virginia, Jiménez, Beatriz, Arasanz, Hugo, Coves, Juan, Majem, Margarita, Massutí, Bartomeu, Vázquez, Sergio, Juan-Vidal, Oscar, Collazo-Lorduy, Ana, Gozálvez, Clara L., Del Barco, Edel, Rosero, Adriana, Bosch-Barrerra, Joaquim, Moreno, María A., Mielgo-Rubio, Xabier, Villa, José C., López-Martin, Ana, Córdoba, Juan F., de Asís Aparisi, Francisco, Zafra, Marta, Mosquera, Joaquín, Pérez Altozano, Javier, Nadal, Ernest, Catot, Silvia, Balsalobre, José, de Portugal, Teresa, Martín, Paloma, Cuesta de Juan, Susana, Cobo, Manuel

Get full text

Characteristics and outcomes of advanced melanoma patients with complete response and elective discontinuation of first‐line anti‐programmed death‐1 monotherapy: A real‐world multicentre observational cohort study by Ochenduszko, Sebastian, García Sanchez, Javier, Fita, María José Juan, González‐Barrallo, Inés, Herrero Colomina, Julio, Mujika, Karmele, Beveridge, Roberto Diaz, Martínez, Silverio Ros, Lafuente, Blanca Sánchez, Tomas, Alberto Cunquero, Jaime, Alfonso Berrocal, Cerezuela Fuentes, Pablo, Fra, Pablo Luna, Peeters, Alicia Gervás, Meana García, José Andrés, García, María Asunción Algarra, Altozano, Javier Perez, Cancela, Maria, Puchades, Almudena Mateu, Roca, Francisco Ferrando, Maiques, Inmaculada Maestu

“…Anti‐programmed death‐1 (anti‐PD1) treatment has significantly improved outcomes of advanced melanoma with a considerable percentage of patients achieving…”
Get full text

Differences in cerebrospinal fluid inflammatory cell reaction of patients with leptomeningeal involvement by lymphoma and carcinoma by Illán, Julia, Simo, Marta, Serrano, Cristina, Castañón, Susana, Gonzalo, Raquel, Martínez-García, María, Pardo, Javier, Gómez, Lidia, Navarro, Miguel, Altozano, Javier Pérez, Álvarez, Ruth, Bruna, Jordi, Subirá, Dolores

“…Dissemination of neoplastic cells into the cerebrospinal fluid (CSF) and leptomeninges is a devastating complication in patients with epithelial cell neoplasia…”
Get full text

Comprehensive cross‐platform comparison of methods for non‐invasive EGFR mutation testing: results of the RING observational trial by Romero, Atocha, Jantus‐Lewintre, Eloisa, García‐Peláez, Beatriz, Royuela, Ana, Insa, Amelia, Cruz, Patricia, Collazo, Ana, Pérez Altozano, Javier, Vidal, Oscar Juan, Diz, Pilar, Cobo, Manuel, Hernández, Berta, Vázquez Estevez, Sergio, Benítez, Gretel, Guirado, Maria, Majem, Margarita, Bernabé, Reyes, Ortega, Ana Laura, Blasco, Ana, Bosch‐Barrera, Joaquim, Jurado, Jose M., García González, Jorge, Viteri, Santiago, Garcia Giron, Carlos, Massutí, Bartomeu, Lopez Martín, Ana, Rodriguez‐Festa, Alejandro, Calabuig‐Fariñas, Silvia, Molina‐Vila, Miguel Ángel, Provencio, Mariano

“…Plasma samples from 72 EGFR‐mutant advanced NSCLC patients, collected upon progression to first‐line TKI, were analyzed by seven methodologies (two NGS‐based…”
Get full text

Real-world study on characteristics of advanced melanoma patients with sustained complete response (CR) after elective 1 st line anti-programmed death-1 (anti-PD1) monotherapy discontinuation by Ochenduszko, Sebastian, García, Javier, Juan-Fita, María Jose, Gonzalez-Barrallo, Ines, Herrero Colomina, Julio, Diaz Beveridge, Robert, Ros Martinez, Silverio, Sanchez Lafuente, Blanca, Cunquero Tomas, Alberto Jacobo, Berrocal, Alfonso, Cerezuela-Fuentes, Pablo, Luna Fra, Pablo, Gervás Peeters, Alicia, Sanchez Gonzalez, José Luis, Meana Garcia, Andres, Algarra Garcia, Mariasun, Palomares García, Eugenio, Perez Altozano, Javier, Tallón Guerola, Mónica, Maestu, Inmaculada

“…e21529 Background: Previous reports proved the feasibility of immunotherapy (IT) discontinuation in advanced melanoma (MEL) patients (pts) in case of CR. We…”
Get full text

Comprehensive cross-platform comparison of methodologies for noninvasive EGFR mutation testing: Results of the RING observational trial by Romero, Atocha, Molina-Vila, Miguel Angel, Jantus-Lewintre, Eloisa, Insa, Amelia, Cruz, Patricia, Collazo, Ana, Perez Altozano, Javier, Juan-Vidal, Oscar, Diz, Pilar, Cobo, Manuel, Hernandez, Berta, Vazquez-Estevez, Sergio, Benitez, Gretel, Guirado, Maria, Rodriguez-Festa, Alejandro, Calabuig-Fariñas, Silvia, Rosell, Rafael, Camps, Carlos, Royuela, Ana, Provencio-Pulla, Mariano

“…Abstract only e21518 Background: Several platforms for non-invasive EGFR testing are currently used in the clinical setting, with sensitivities ranging from 30…”
Get full text

Dabrafenib plus trametinib for compassionate use in metastatic melanoma: A STROBE-compliant retrospective observational postauthorization study by Martín Algarra, Salvador, Soriano, Virtudes, Fernández-Morales, Luis, Berciano-Guerrero, Miguel-Ángel, Mujika, Karmele, Manzano, José Luis, Puértolas Hernández, Teresa, Soria, Ainara, Rodríguez-Abreu, Delvys, Espinosa Arranz, Enrique, Medina Martínez, Javier, Márquez-Rodas, Ivan, Rubió-Casadevall, Jordi, Ortega, María Eugenia, Jurado García, José Miguel, Lecumberri Biurrun, María José, Palacio, Isabel, Rodríguez de la Borbolla Artacho, María, Altozano, Javier Pérez, Castellón Rubio, Victoria Eugenia, García, Almudena, Luna, Pablo, Ballesteros, Anabel, Fernández, Ovidio, López Martín, Jose Antonio, Berrocal, Alfonso, Arance, Ana

“…The main objective of the study was to evaluate the efficacy and safety of dabrafenib alone or combined with trametinib for compassionate use in patients with…”
Get full text